380 related articles for article (PubMed ID: 35153470)
1. Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer.
Hirahata T; Ul Quraish R; Quraish AU; Ul Quraish S; Naz M; Razzaq MA
Cancer Inform; 2022; 21():11769351221076062. PubMed ID: 35153470
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy in Colorectal Carcinoma: Clinical Applications and Challenges.
Kolenčík D; Shishido SN; Pitule P; Mason J; Hicks J; Kuhn P
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32471160
[TBL] [Abstract][Full Text] [Related]
4. Current and future applications of liquid biopsy in non-small-cell lung cancer-a narrative review.
Tomasik B; Skrzypski M; Bieńkowski M; Dziadziuszko R; Jassem J
Transl Lung Cancer Res; 2023 Mar; 12(3):594-614. PubMed ID: 37057121
[TBL] [Abstract][Full Text] [Related]
5. Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update.
Kapeleris J; Ebrahimi Warkiani M; Kulasinghe A; Vela I; Kenny L; Ladwa R; O'Byrne K; Punyadeera C
Front Oncol; 2022; 12():859152. PubMed ID: 35372000
[TBL] [Abstract][Full Text] [Related]
6. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
Adhit KK; Wanjari A; Menon S; K S
Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
[TBL] [Abstract][Full Text] [Related]
7. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
8. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy.
Wang X; Wang L; Lin H; Zhu Y; Huang D; Lai M; Xi X; Huang J; Zhang W; Zhong T
Front Oncol; 2024; 14():1303335. PubMed ID: 38333685
[TBL] [Abstract][Full Text] [Related]
9. Advanced liquid biopsy technologies for circulating biomarker detection.
Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
[TBL] [Abstract][Full Text] [Related]
10. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
Zhang X; Ju S; Wang X; Cong H
Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.
Tan CR; Zhou L; El-Deiry WS
Curr Colorectal Cancer Rep; 2016 Jun; 12(3):151-161. PubMed ID: 27516729
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
[TBL] [Abstract][Full Text] [Related]
14. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer.
Heidrich I; Abdalla TSA; Reeh M; Pantel K
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572727
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
16. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
17. Overview of the role of liquid biopsy in cancer management.
Assi T; Khoury R; Ibrahim R; Baz M; Ibrahim T; LE Cesne A
Transl Oncol; 2023 Aug; 34():101702. PubMed ID: 37267803
[TBL] [Abstract][Full Text] [Related]
18. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
19. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
Liu S; Wang J
Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
[TBL] [Abstract][Full Text] [Related]
20. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
Yaghoubi Naei V; Bordhan P; Mirakhorli F; Khorrami M; Shrestha J; Nazari H; Kulasinghe A; Ebrahimi Warkiani M
Ther Adv Med Oncol; 2023; 15():17588359231192401. PubMed ID: 37692363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
